Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183: 109119.

Article  PubMed  Google Scholar 

Rendell M, Lassek WD, Ross DA, Smith C, Kernek S, Williams J, et al. A pharmaceutical profile of diabetic patients. J Chronic Dis. 1983;36(2):193–202.

Article  CAS  PubMed  Google Scholar 

Angiolillo DJ, Jakubowski JA, Ferreiro JL, Tello-Montoliu A, Rollini F, Franchi F, et al. Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease. J Am Coll Cardiol. 2014;64(10):1005–14.

Article  CAS  PubMed  Google Scholar 

Dostalek M, Sam W-J, Paryani KR, Macwan JS, Gohh RY, Akhlaghi F. Diabetes mellitus reduces the clearance of atorvastatin lactone: results of a population pharmacokinetic analysis in renal transplant recipients and in vitro studies using human liver microsomes. Clin Pharmacokinet. 2012;51(9):591–606.

Article  CAS  PubMed  Google Scholar 

Iida M, Ikeda M, Kishimoto M, Tsujino T, Kaneto H, Matsuhisa M, et al. Evaluation of gut motility in type II diabetes by the radiopaque marker method. J Gastroenterol Hepatol. 2000;15(4):381–5.

Article  CAS  PubMed  Google Scholar 

Dostalek M, Akhlaghi F, Puzanovova M. Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs. Clin Pharmacokinet. 2012;51(8):481–99.

Article  CAS  PubMed  Google Scholar 

Triantafyllou K, Kalantzis C, Papadopoulos AA, Apostolopoulos P, Rokkas T, Kalantzis N, et al. Video-capsule endoscopy gastric and small bowel transit time and completeness of the examination in patients with diabetes mellitus. Dig Liver Dis. 2007;39(6):575–80.

Article  CAS  PubMed  Google Scholar 

Okabe N, Hashizume N. Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism. Biol Pharm Bull. 1994;17(1):16–21.

Article  CAS  PubMed  Google Scholar 

Tziomalos K, Athyros VG. Diabetic nephropathy: new risk factors and improvements in diagnosis. Rev Diabet Stud. 2015;12(1–2):110–8.

Article  PubMed  PubMed Central  Google Scholar 

Wang Z, Yang H, Xu J, Zhao K, Chen Y, Liang L, et al. Prediction of atorvastatin pharmacokinetics in high-fat diet and low-dose streptozotocin-induced diabetic rats using a semiphysiologically based pharmacokinetic model involving both enzymes and transporters. Drug Metab Dispos. 2019;47(10):1066–79.

Article  CAS  PubMed  Google Scholar 

Edginton AN, Theil F-P, Schmitt W, Willmann S. Whole body physiologically-based pharmacokinetic models: their use in clinical drug development. Expert Opin Drug Metab Toxicol. 2008;4(9):1143–52.

Article  CAS  PubMed  Google Scholar 

Perry C, Davis G, Conner TM, Zhang T. Utilization of physiologically based pharmacokinetic modeling in clinical pharmacology and therapeutics: an overview. Curr Pharmacol Rep. 2020;6(3):71–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barter ZE, Tucker GT, Rowland-Yeo K. Differences in cytochrome p450-mediated pharmacokinetics between chinese and caucasian populations predicted by mechanistic physiologically based pharmacokinetic modelling. Clin Pharmacokinet. 2013;52(12):1085–100.

Article  CAS  PubMed  Google Scholar 

Zhou W, Johnson TN, Bui KH, Cheung SYA, Li J, Xu H, et al. Predictive Performance of Physiologically Based Pharmacokinetic (PBPK) Modeling of Drugs Extensively Metabolized by Major Cytochrome P450s in Children. Clin Pharmacol Ther. 2018;104(1):188–200.

Article  CAS  PubMed  Google Scholar 

Alqahtani F, Asiri AM, Zamir A, Rasool MF, Alali AS, Alsanea S, et al. Predicting hydroxychloroquine clearance in healthy and diseased populations using a physiologically based pharmacokinetic approach. Pharmaceutics. 2023;15(4):1250.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang X, Zhuang Y, Xu Z, Wang W, Zhou H. Development of a physiologically based pharmacokinetic model to predict disease-mediated therapeutic protein-drug interactions: modulation of multiple cytochrome P450 enzymes by interleukin-6. AAPS J. 2016;18(3):767–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Edginton AN, Willmann S. Physiology-based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosis. Clin Pharmacokinet. 2008;47(11):743–52.

Article  PubMed  Google Scholar 

Ghobadi C, Johnson TN, Aarabi M, Almond LM, Allabi AC, Rowland-Yeo K, et al. Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance. Clin Pharmacokinet. 2011;50(12):809–22.

Article  CAS  PubMed  Google Scholar 

Harreiter J, Roden M. Diabetes mellitus: definition, classification, diagnosis, screening and prevention (Update 2023). Wien Klin Wochenschr. 2023;135(Suppl 1):7–17.

Article  PubMed  PubMed Central  Google Scholar 

Wilson GA, Wilkins GT, Cotter JD, Lamberts RR, Lal S, Baldi JC. Impaired ventricular filling limits cardiac reserve during submaximal exercise in people with type 2 diabetes. Cardiovasc Diabetol. 2017;16(1):160.

Article  PubMed  PubMed Central  Google Scholar 

Kobayashi Y, Christle JW, Contrepois K, Nishi T, Moneghetti K, Cauwenberghs N, et al. Peripheral oxygen extraction and exercise limitation in asymptomatic patients with diabetes mellitus. Am J Cardiol. 2021;149:132–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zafari N, Lotfaliany M, O’Keefe GJ, Kishore K, Torkamani N, MacIsaac RJ, et al. Performance of 4 creatinine-based equations in assessing glomerular filtration rate in adults with diabetes. J Clin Endocrinol Metab. 2021;106(1):e61–73.

Article  PubMed  Google Scholar 

Chun-guang Y, Wei W. Formualtion of nisoldipine sustained release tablets. Chin J New Drugs. 2004;13(10):904–6.

Google Scholar 

Zhou M, Xia L, Wang J. Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine. Drug Metab Dispos. 2007;35(10):1956–62.

Article  CAS  PubMed  Google Scholar 

Poulin P, Theil F-P. Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution. J Pharm Sci. 2002;91(1):129–56.

Article  CAS  PubMed  Google Scholar 

Rodgers T, Rowland M. Mechanistic approaches to volume of distribution predictions: understanding the processes. Pharm Res. 2007;24(5):918–33.

Article  CAS  PubMed  Google Scholar 

Sawada Y, Hanano M, Sugiyama Y, Harashima H, Iga T. Prediction of the volumes of distribution of basic drugs in humans based on data from animals. J Pharmacokinet Biopharm. 1984;12(6):587–96.

Article  CAS  PubMed  Google Scholar 

Perdaems N, Blasco H, Vinson C, Chenel M, Whalley S, Cazade F, et al. Predictions of metabolic drug–drug interactions using physiologically based modelling: Two cytochrome P450 3A4 substrates coadministered with ketoconazole or verapamil. Clin Pharmacokinet. 2010;49(4):239–58.

Article  CAS  PubMed  Google Scholar 

Chiang C-W, Zhang P, Wang X, Wang L, Zhang S, Ning X, et al. Translational high-dimensional drug interaction discovery and validation using health record databases and pharmacokinetics models. Clin Pharmacol Ther. 2018;103(2):287–95.

Article  CAS  PubMed  Google Scholar 

Ekinci EI, Hughes JT, Chatfield MD, Lawton PD, Jones GRD, Ellis AG, et al. Hyperfiltration in Indigenous Australians with and without diabetes. Nephrol Dial Transplant. 2015;30(11):1877–84.

Article  CAS  PubMed  Google Scholar 

Premaratne E, Macisaac RJ, Tsalamandris C, Panagiotopoulos S, Smith T, Jerums G. Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate. Diabetologia. 2005;48(12):2486–93.

Article  CAS  PubMed  Google Scholar 

Leonard CE, Bilker WB, Brensinger CM, Han X, Flory JH, Flockhart DA, et al. Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics. Clin Pharmacol Ther. 2016;99(5):538–47.

Article  CAS  PubMed  Google Scholar 

Niemi M, Backman JT, Neuvonen M, Laitila J, Neuvonen PJ, Kivistö KT. Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride. Clin Pharmacol Ther. 2001;69(4):194–200.

Article  CAS  PubMed  Google Scholar 

Wei Y, Lin F-J, Lin S-Y, Wang C-C. Risk of hypoglycemia and concomitant use of repaglinide and clopidogrel: a population-based nested case-control study. Clin Pharmacol Ther. 2019;106(6):1346–52.

Article  CAS  PubMed  Google Scholar 

Gravel S, Chiasson J-L, Turgeon J, Grangeon A, Michaud V. Modulation of CYP450 Activities in Patients With Type 2 Diabetes. Clin Pharmacol Ther. 2019;106(6):1280–9.

Article  CAS  PubMed